Navigation Links
Rare cell prevents rampant brain activity

One of the mysteries of the brain is how it avoids ending up in a state of chaos, something which happens only on exceptional occasions, when it can lead to epileptic fits. Scientists at Karolinska Institutet have now uncovered a new mechanism controlling how the brain keeps its neuronal activity in check.

The human brain consists of around a hundred million nerve cells linked together by around ten billion contact junctions called synapses. The activity of this extremely complex network is regulated through a dynamic balance between excitatory signals, which are transmitted by one type of synapse, and inhibitory counter-signals, which are transmitted by another.

An imbalance between excitatory and inhibitory activity is associated with diseases such as epilepsy, schizophrenia, and anxiety. But despite the fact that excitatory synapses are much more common than their inhibitory counterparts, the system is generally kept in a state of equilibrium. Just how the brain manages this feat is a puzzle to scientists.

Scientists at Karolinska Institutet and the Brain Mind Institute in Switzerland have now discovered a mechanism that might explain how the most common type of neuron in the cerebral cortex ?the pyramid cell ?is prevented from becoming over-activated. Their results show that a rarer cell type that links collections of pyramid cells ?called a Martinotti cell ?acts as a kind of safety device. When a Martinotti cell receives signals above a certain frequency, it responds by sending back inhibitory signals that moderate surrounding pyramid cells.

Gilad Silberberg, one of the researchers behind the study, believes that the mechanism is essential to understanding brain disorders like epilepsy.

"A characteristic feature of epilepsy is the hyperactivation of cortical pyramid cells, which is exactly what this mechanism inhibits. It is possible that epilepsy is related to a deficit of Martinotti cells or a deficiency of M artinotti activity in the brain."


'"/>

Source:Karolinska Institutet


Related biology news :

1. Protein prevents detrimental immune effects of bacterial sepsis
2. Chemical band-aid prevents heart failure in mice with muscular dystrophy
3. EGF receptor activation prevents microbes from going more than skin deep
4. Gene therapy prevents the onset of diabetic symptoms in mice
5. Three-in-one virus killer prevents common, often fatal infections
6. Vaccination with embryonic stem cells prevents lung cancer in mice
7. Antibody therapy prevents type 1 diabetes in mice
8. New compound prevents alcoholic behavior, relapse in animals by blocking stress response
9. Vaccine prevents prion disease in mice
10. MUHC scientists describe genetic resistance to rampant virus
11. Controversial drug shown to act on brain protein to cut alcohol use
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced Design ... will feature emerging and evolving technology through its ... Summits will run alongside the expo portion of the ... panels and demonstrations focused on trending topics within 3D ... design and manufacturing event will take place June 13-15, 2017 ...
(Date:4/11/2017)... , Apr. 11, 2017 Research and Markets ... 2017-2021" report to their offering. ... The global eye tracking market to grow at a CAGR ... Global Eye Tracking Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
(Date:4/6/2017)... -- Forecasts by Product Type (EAC), Biometrics, ... (Transportation & Logistics, Government & Public Sector, Utilities / ... Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality ... looking for a definitive report on the $27.9bn Access ... ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... any gene in its endogenous context, enabling overexpression experiments and avoiding the use ... with small RNA guides is transformative for performing systematic gain-of-function studies. , ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... innovation and business process optimization firm for the life sciences and healthcare industries, ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile ...
Breaking Biology Technology: